A carregar...
Drug therapies for chronic hepatitis C infection: a cost-effectiveness analysis
BACKGROUND: Before 2011, pegylated interferon plus ribavirin was the standard therapy for chronic hepatitis C. Interferon-free direct-acting antiviral agents were then approved. Although these treatments appear to be more effective, they are substantially more expensive. In anticipation of the need...
Na minha lista:
| Publicado no: | CMAJ Open |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Joule Inc. or its licensors
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5378540/ https://ncbi.nlm.nih.gov/pubmed/28401125 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.9778/cmajo.20160161 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|